ATE213162T1 - Thymus-stammendes, immunverstärkendes agens zur therapeutischen verwendung in einem wirt mit einem angegriffenen immunsystem - Google Patents

Thymus-stammendes, immunverstärkendes agens zur therapeutischen verwendung in einem wirt mit einem angegriffenen immunsystem

Info

Publication number
ATE213162T1
ATE213162T1 AT93908285T AT93908285T ATE213162T1 AT E213162 T1 ATE213162 T1 AT E213162T1 AT 93908285 T AT93908285 T AT 93908285T AT 93908285 T AT93908285 T AT 93908285T AT E213162 T1 ATE213162 T1 AT E213162T1
Authority
AT
Austria
Prior art keywords
immune
thym
attacked
host
therapeutic use
Prior art date
Application number
AT93908285T
Other languages
English (en)
Inventor
Terry R Beardsley
Original Assignee
Terry R Beardsley
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Terry R Beardsley filed Critical Terry R Beardsley
Application granted granted Critical
Publication of ATE213162T1 publication Critical patent/ATE213162T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT93908285T 1992-03-13 1993-03-09 Thymus-stammendes, immunverstärkendes agens zur therapeutischen verwendung in einem wirt mit einem angegriffenen immunsystem ATE213162T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US85058692A 1992-03-13 1992-03-13
PCT/US1993/002056 WO1993017700A1 (en) 1992-03-13 1993-03-09 Immune-enhancing agent for therapeutic use in immunocompromised hosts

Publications (1)

Publication Number Publication Date
ATE213162T1 true ATE213162T1 (de) 2002-02-15

Family

ID=25308567

Family Applications (1)

Application Number Title Priority Date Filing Date
AT93908285T ATE213162T1 (de) 1992-03-13 1993-03-09 Thymus-stammendes, immunverstärkendes agens zur therapeutischen verwendung in einem wirt mit einem angegriffenen immunsystem

Country Status (8)

Country Link
US (1) US5616554A (de)
EP (1) EP0630257B1 (de)
JP (1) JPH07504662A (de)
AT (1) ATE213162T1 (de)
AU (2) AU3916093A (de)
CA (1) CA2131709C (de)
DE (1) DE69331574T2 (de)
WO (1) WO1993017700A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1663280B1 (de) * 2003-09-10 2009-08-05 S-Cell Biosciences, Inc. Zusammensetzungen basierend auf T-4 Immunstimulierender-Faktor ("TISF") zur Behandlung von Mangel and roten Blutkörperchen, Granulocyten un Blutplättchen
EP1928498A4 (de) * 2005-09-29 2009-11-11 Cell Biosciences Inc S Verfahren zur behandlung von t-zell-störungen mit tisf
AU2008211199A1 (en) * 2007-01-26 2008-08-07 The Regents Of The University Of Colorado Methods of modulating immune function
WO2008101037A1 (en) * 2007-02-14 2008-08-21 S-Cell Biosciences, Inc. Method to treat inflammation
US8957031B2 (en) * 2007-10-23 2015-02-17 Regents Of The University Of Colorado, A Body Corporate Competitive inhibitors of invariant chain expression and/or ectopic clip binding
CA2730773A1 (en) 2008-07-14 2010-01-21 Martha Karen Newell Methods and products for treating proliferative diseases
US20100166782A1 (en) * 2008-07-25 2010-07-01 Martha Karen Newell Clip inhibitors and methods of modulating immune function
CA2736842A1 (en) * 2008-07-25 2010-01-28 The Regents Of The University Of Colorado Proteins for use in diagnosing and treating infection and disease
EP2323681A4 (de) * 2008-07-25 2012-11-14 Univ Colorado Verfahren zur behandlung viraler erkrankungen
US9359404B2 (en) 2011-12-01 2016-06-07 Scott & White Healthcare Methods and products for treating preeclampsia and modulating blood pressure
IL308091B1 (en) * 2016-09-13 2026-01-01 Allergan Inc Protein-free stabilized Clostridium toxin preparations

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4120951A (en) * 1975-08-22 1978-10-17 Sloan-Kettering Institute For Cancer Research Polypeptide hormones of the thymus
US4720482A (en) * 1982-10-20 1988-01-19 Dana Farber Cancer Institute Pharmaceutical compositions containing one or more lymphocyte growth factors
US4722998A (en) * 1982-10-20 1988-02-02 Dana Farber Cancer Institute Method of producing lymphocyte growth factors
US4571336A (en) * 1983-08-25 1986-02-18 Endorphin, Inc. Immune stimulation
US4814434A (en) * 1984-02-03 1989-03-21 Ventres Laboratories, Inc. Inducer of T-suppressor cells
US4716148A (en) * 1984-08-13 1987-12-29 Hoffman-La Roche Inc. Prothymosin alpha
IT1196958B (it) * 1986-07-10 1988-11-25 Ellem Ind Farmaceutica Derivato di timo attivo per via orale, procedimenti per la sua preparazione e relative composizioni farmaceutiche
JPS6490199A (en) * 1987-09-30 1989-04-06 Hiromi Fujiwara T cell growth factor derived from thymic interstitial cell and production thereof
US4965195A (en) * 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7

Also Published As

Publication number Publication date
CA2131709A1 (en) 1993-09-16
AU3916093A (en) 1993-10-05
US5616554A (en) 1997-04-01
CA2131709C (en) 2004-11-23
EP0630257A4 (de) 1996-01-17
WO1993017700A1 (en) 1993-09-16
EP0630257B1 (de) 2002-02-13
JPH07504662A (ja) 1995-05-25
EP0630257A1 (de) 1994-12-28
DE69331574D1 (de) 2002-03-21
AU4001997A (en) 1998-01-08
AU714534B2 (en) 2000-01-06
DE69331574T2 (de) 2002-10-02

Similar Documents

Publication Publication Date Title
ATE213162T1 (de) Thymus-stammendes, immunverstärkendes agens zur therapeutischen verwendung in einem wirt mit einem angegriffenen immunsystem
IT1272852B (it) "sistema di controllo per oggetti e procedimento per controllare oggetti"
MA23065A1 (fr) Microspheres de proteines vegetales modifies hydrolysees et leurs procedes de preparation et d'utilisation.
DE69210128D1 (de) Rechnerautomatisiertes system zur identifizierung von patienten und röntgenaufnahmen
WO1994007542A3 (en) Labelled monocyte chemoattractant protein material and medical uses thereof
DE3855919D1 (de) System zur Isolierung und Identifizierung von Leukozyten
FI900708A7 (fi) Ihmisen immuunisysteemi eläimessä
DE3767409D1 (de) Elektromagnetisches identifizierungs- und ortungssystem.
ITTO930149A1 (it) Contenitore di animali marini vivi
IT1200382B (it) Sistema di rilevazione e/o dosaggio di parametri clinici per via immuno enzimatica
SE9002589L (sv) Neutrofil-aktiverande peptid-2
IT8767994A0 (it) Procedimento e impianto per la denaturazione di vernici
DE69833876D1 (de) Zusammensetzungen und methoden zur zielgerichteten abgabe von biologisch aktivenfaktoren
IL115671A0 (en) Use of protease inhibitors and protease vaccines to protect animals from flea infestation and flea protease proteins nucleic acid molecules and uses thereof
FR2735983B1 (fr) Peptide permettant de modifier l'activite du systeme immunitaire humain ou animal
GEP20012571B (en) New Application of Lyzocyme Dimer
IT1248947B (it) Sistema di connessione per pale di elica di aeroplano
CA2012414A1 (en) Hog cholera virus vaccine and diagnostic
IT8703372A0 (it) Sistema di collegamento rapido edi fissaggio di complesso elettronico per illuminazione
DE69429521D1 (de) Zusammensetzung und verfahren zur stimulation der reproduzierenden leistung
GEP20012489B (en) Use of Natural Human α-Interferon
KR910004802A (ko) 긴팔원숭이 백혈병 비루스 리셉터 단백질, 이를 암호화하는 단리된 정제 dna 서열 및 이들을 동정하는 방법
ATE145115T1 (de) Verwendung von dioldiestern in hunde- und katzenfutter
LV11667A (lv) Imunomodulejosas darbibas un sunu audu vairosanas regulacijas sistemas traucetas funkcionesanas atjaunosanas lidzekli
FR2633628B1 (fr) Procede de preparation de polylactones d'acides poly-((alpha)-hydroxy-(acryliques et/ou crotoniques))

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties